General Information of the Compound
Compound ID
CP0526953
Compound Name
N-[4-bromo-5-(2-methyl-1,3-thiazol-4-yl)-1H-pyrazol-3-yl]-2-chlorobenzamide
    Show/Hide
Structure
Formula
C14H10BrClN4OS
Molecular Weight
397.685
Canonical SMILES
Cc1nc(cs1)-c1n[nH]c(NC(=O)c2ccccc2Cl)c1Br
    Show/Hide
InChI
InChI=1S/C14H10BrClN4OS/c1-7-17-10(6-22-7)12-11(15)13(20-19-12)18-14(21)8-4-2-3-5-9(8)16/h2-6H,1H3,(H2,18,19,20,21)
    Show/Hide
InChIKey
JHEXJESEDYTEIN-UHFFFAOYSA-N
Physicochemical Property
logP
4.50982
Rotatable Bonds
3
Heavy Atom Count
22
Polar Areas
70.67
Hydrogen Bond Donor Count
2
Hydrogen Bond Acceptor Count
4
Complexity
22

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 44428100
ChEMBL ID
CHEMBL398008
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound

Compound
Cell Line
Protein

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01032, B1 bradykinin receptor
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000411 IMR-90 Homo sapiens (Human)  1
1
IC50 = 1100 nM
   TI
   LI
   LO
   TS